Europe Metabolomics Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Metabolomics Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Metabolomics Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Metabolomics Services Market Regional Analysis

6.2 Europe Metabolomics Services Market Revenue 2019-2028 (US$ Million)

6.3 Europe Metabolomics Services Market Forecast Analysis

7. Europe Metabolomics Services Market Analysis – by Service Type

7.1 Targeted Metabolomics Service and Untargeted Metabolomics Service

7.1.1 Overview
7.1.2 Targeted Metabolomics Service and Untargeted Metabolomics Service: Europe Metabolomics Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Metabolomics Services Market Analysis – by Application

8.1 Pharmaceutical and Biotechnology Industry

8.1.1 Overview
8.1.2 Pharmaceutical and Biotechnology Industry: Europe Metabolomics Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Agritech

8.2.1 Overview
8.2.2 Agritech: Europe Metabolomics Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Environment

8.3.1 Overview
8.3.2 Environment : Europe Metabolomics Services Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Metabolomics Services Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Metabolomics Services Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 Europe Metabolomics Services Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 UK: Europe Metabolomics Services Market Breakdown, by Service Type
9.2.1.1.2 UK: Europe Metabolomics Services Market Breakdown, by Application

9.2.1.2 Germany: Europe Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Germany: Europe Metabolomics Services Market Breakdown, by Service Type
9.2.1.2.2 Germany: Europe Metabolomics Services Market Breakdown, by Application

9.2.1.3 France: Europe Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 France: Europe Metabolomics Services Market Breakdown, by Service Type
9.2.1.3.2 France: Europe Metabolomics Services Market Breakdown, by Application

9.2.1.4 Russia: Europe Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.4.1 Russia: Europe Metabolomics Services Market Breakdown, by Service Type
9.2.1.4.2 Russia: Europe Metabolomics Services Market Breakdown, by Application

9.2.1.5 Italy: Europe Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.5.1 Italy: Europe Metabolomics Services Market Breakdown, by Service Type
9.2.1.5.2 Italy: Europe Metabolomics Services Market Breakdown, by Application

9.2.1.6 Rest of Europe: Europe Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Metabolomics Services Market Breakdown, by Service Type
9.2.1.6.2 Rest of Europe: Europe Metabolomics Services Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Afekta Technologies Ltd.

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 BASF SE

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 biocrates life sciences ag

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Creative Proteomics

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Fred Hutchinson Cancer Research Center

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Metabolon, Inc.

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 metaSysX

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 MS-Omics

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 RTI International

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Metabolomics Services Market

Analysis By Service Type (Targeted Metabolomics Service and Untargeted Metabolomics Service) and Application (Pharmaceutical and Biotechnology Industry, Agritech, and Environment)